112 related articles for article (PubMed ID: 25688519)
1. Synthesis and Biological Evaluation of Oxygen-containing Heterocyclic Ring-fused 23-Hydroxybetulinic Acid Derivatives as Antitumor Agents.
Zhang H; Li F; Zhu P; Liu J; Yao H; Jiang J; Ye W; Wu X; Xu J
Chem Biol Drug Des; 2015 Oct; 86(4):424-31. PubMed ID: 25688519
[TBL] [Abstract][Full Text] [Related]
2. Synthesis, in vitro and in vivo antitumor activity of pyrazole-fused 23-hydroxybetulinic acid derivatives.
Zhang H; Zhu P; Liu J; Lin Y; Yao H; Jiang J; Ye W; Wu X; Xu J
Bioorg Med Chem Lett; 2015 Feb; 25(3):728-32. PubMed ID: 25529742
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and antiproliferative evaluation of 23-hydroxybetulinic acid derivatives.
Lan P; Wang J; Zhang DM; Shu C; Cao HH; Sun PH; Wu XM; Ye WC; Chen WM
Eur J Med Chem; 2011 Jun; 46(6):2490-502. PubMed ID: 21496972
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and antitumor activity of novel 3-oxo-23-hydroxybetulinic acid derivatives.
Zhang H; Zhu P; Liu J; Yang X; Xu S; Yao H; Jiang J; Ye W; Wu X; Xu J
Eur J Med Chem; 2014 Nov; 87():159-67. PubMed ID: 25247772
[TBL] [Abstract][Full Text] [Related]
5. Design, synthesis and antitumor activity of triterpenoid pyrazine derivatives from 23-hydroxybetulinic acid.
Zhang H; Wang Y; Zhu P; Liu J; Xu S; Yao H; Jiang J; Ye W; Wu X; Xu J
Eur J Med Chem; 2015 Jun; 97():235-44. PubMed ID: 25984840
[TBL] [Abstract][Full Text] [Related]
6. Synthesis, biological evaluation and mechanism studies of C-23 modified 23-hydroxybetulinic acid derivatives as anticancer agents.
Lu L; Zhang H; Liu J; Liu Y; Wang Y; Xu S; Zhu Z; Xu J
Eur J Med Chem; 2019 Nov; 182():111659. PubMed ID: 31491611
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and biological activity of 28-amide derivatives of 23-hydroxy betulinic Acid as antitumor agent candidates.
Bi Y; Xu J; Sun F; Wu X; Ye W; Sun Y; Huang W
Med Chem; 2013 Nov; 9(7):920-5. PubMed ID: 23083117
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and biological activity of 23-hydroxybetulinic acid C-28 ester derivatives as antitumor agent candidates.
Bi Y; Xu J; Sun F; Wu X; Ye W; Sun Y; Huang W
Molecules; 2012 Jul; 17(8):8832-41. PubMed ID: 22832884
[TBL] [Abstract][Full Text] [Related]
9. Synthesis, biological evaluation and mechanism studies of C-3 substituted nitrogenous heterocyclic 23-Hydroxybetulinic acid derivatives as anticancer agents.
Zhou H; Zhu H; Zha Y; Xu J; Wang T; Xu S
Fitoterapia; 2022 Jul; 160():105222. PubMed ID: 35618147
[TBL] [Abstract][Full Text] [Related]
10. Design, Synthesis, and Biological Evaluation of Novel Nitrogen Heterocycle-Containing Ursolic Acid Analogs as Antitumor Agents.
Wang W; Lei L; Liu Z; Wang H; Meng Q
Molecules; 2019 Mar; 24(5):. PubMed ID: 30832266
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and antitumor activity evaluation of novel ursolic acid derivatives.
Meng YQ; Zhang LF; Liu DY; Liu LW; Zhang Y; Zhao MJ
J Asian Nat Prod Res; 2016; 18(3):280-8. PubMed ID: 26524942
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and cytotoxicity of novel ursolic acid derivatives containing an acyl piperazine moiety.
Liu MC; Yang SJ; Jin LH; Hu DY; Xue W; Song BA; Yang S
Eur J Med Chem; 2012 Dec; 58():128-35. PubMed ID: 23124210
[TBL] [Abstract][Full Text] [Related]
13. Novel rotundic acid derivatives: synthesis, structural characterization and in vitro antitumor activity.
Chen Y; He YF; Nan ML; Sun WY; Hu J; Cui A; Li F; Wang F
Int J Mol Med; 2013 Feb; 31(2):353-60. PubMed ID: 23233042
[TBL] [Abstract][Full Text] [Related]
14. Antiproliferative novel isoxazoles: modeling, virtual screening, synthesis, and bioactivity evaluation.
Tzanetou E; Liekens S; Kasiotis KM; Melagraki G; Afantitis A; Fokialakis N; Haroutounian SA
Eur J Med Chem; 2014 Jun; 81():139-49. PubMed ID: 24836066
[TBL] [Abstract][Full Text] [Related]
15. Design, synthesis and cytotoxicity of cell death mechanism of rotundic acid derivatives.
He YF; Nan ML; Sun JM; Meng ZJ; Li W; Zhang M
Bioorg Med Chem Lett; 2013 May; 23(9):2543-7. PubMed ID: 23558236
[TBL] [Abstract][Full Text] [Related]
16. Design, synthesis and in vitro evaluation of novel ursolic acid derivatives as potential anticancer agents.
Hua SX; Huang RZ; Ye MY; Pan YM; Yao GY; Zhang Y; Wang HS
Eur J Med Chem; 2015 May; 95():435-52. PubMed ID: 25841199
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and antitumor activity of novel 2-(1-substituted-piperidin-4-ylamino)quinazolines as antitumor agents.
Wang YK; Jin J; Zhu LN; Zhang Y; Chen XG; Gao XQ; Xu BL
Yao Xue Xue Bao; 2012 Sep; 47(9):1164-78. PubMed ID: 23227546
[TBL] [Abstract][Full Text] [Related]
18. [Synthesis and antitumor activity of C3 heterocyclic-substituted fluoroquinolone derivatives (I): ciprofloxacin aminothiodiazole Schiff-bases].
Hu GQ; Wu XK; Wang X; Zhang ZQ; Xie SQ; Huang WL; Zhang HB
Yao Xue Xue Bao; 2008 Nov; 43(11):1112-5. PubMed ID: 19239029
[TBL] [Abstract][Full Text] [Related]
19. Design, synthesis and biological activities of sorafenib derivatives as antitumor agents.
Yao J; He Z; Chen J; Sun W; Fang H; Xu W
Bioorg Med Chem Lett; 2012 Nov; 22(21):6549-53. PubMed ID: 23021967
[TBL] [Abstract][Full Text] [Related]
20. In vitro and in vivo anticancer activity evaluation of ursolic acid derivatives.
Shao JW; Dai YC; Xue JP; Wang JC; Lin FP; Guo YH
Eur J Med Chem; 2011 Jul; 46(7):2652-61. PubMed ID: 21514015
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
